Skip to main content

Table 7 The most important side effects rated as strong by patients (VAS ≥50)

From: Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling

Side effect ≥50% Patients with adjuvant CT (n = 58) Patients with palliative CT (n = 6)
Feeling cold 22 (37.9%) 2 (33,3%)
Headache 14 (24.1%) 0
Heaviness of head 11 (18.9%) 0
Scalp pain 6 (10.3%) 1 (16,7%)